Literature DB >> 35672560

Cerebral microbleeds is associated with dementia in Parkinson's disease.

Huijuan Wan1,2,3,4, Huimin Chen5, Meimei Zhang1,2,3, Tao Feng6,7,8, Yilong Wang9,10,11,12.   

Abstract

INTRODUCTION: Emerging evidence suggests that cerebral small vessel disease (CSVD) may worsen cognitive functions in Parkinson's disease (PD). However, the effect of microbleeds on cognitive function in patients with PD remains unknown. This study explored the association between the presence, number and location of microbleeds with dementia in PD patients.
METHODS: This cross-sectional study included 431 patients with PD from Beijing Tiantan Hospital from May 2016 to August 2019. Cognition assessments (MMSE, MoCA) were performed for these patients. MRI imaging sequences were obtained and reviewed independently by two well-trained readers who were blind to all clinical data. Spearman's correlation analysis and logistic regression model analysis were further used for the assessments.
RESULTS: An association between cerebral microbleeds with cognitive ability and dementia in PD patients was revealed. A significance was observed between the total number of microbleeds and two widely used scores of cognitive assessments (Spearman R = - 0.120 to MMSE with a p = 0.016, and - 0.117 to MoCA with a p = 0.020). In detail, infratentorial microbleeds were associated with the level of cognition in PD patients (Spearman R = - 0.099 to MMSE with a p = 0.049, and - 0.116 to MoCA with a p = 0.021). Furthermore, logistic regression analysis results also confirmed such correlations between the number of microbleeds and cognitive ability after adjusting for age, cholesterol level, Hamilton Anxiety Scale, Hamilton Depression Scale, and white matter hyperintensity Fazekas score (OR 3.28, p = 0.035, 95% CI 1.090-9.892).
CONCLUSIONS: The occurrence of microbleeds, especially in the infratentorial locations, may worsen the cognitive function of PD patients and result in dementia. Management of cerebral vascular disease could be beneficial to patients with PD.
© 2022. The Author(s) under exclusive licence to Belgian Neurological Society.

Entities:  

Keywords:  Cerebral small vessel disease; Cognitive malfunction; Parkinson’s disease

Year:  2022        PMID: 35672560     DOI: 10.1007/s13760-022-01918-z

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  21 in total

1.  Characterization of cerebral microbleeds in idiopathic Parkinson's disease.

Authors:  J-H Kim; J Park; Y-H Kim; H-I Ma; Y J Kim
Journal:  Eur J Neurol       Date:  2014-11-04       Impact factor: 6.089

2.  Cerebral microbleeds in the elderly: a pathological analysis.

Authors:  Mark Fisher; Samuel French; Ping Ji; Ronald C Kim
Journal:  Stroke       Date:  2010-10-28       Impact factor: 7.914

Review 3.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

4.  Cerebral microbleeds in patients with Parkinson's disease.

Authors:  Jee Hyun Ham; Han Yi; Mun Kyung Sunwoo; Jin Yong Hong; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2014-06-12       Impact factor: 4.849

5.  Association of Cerebral Microbleeds With Cognitive Decline and Dementia.

Authors:  Saloua Akoudad; Frank J Wolters; Anand Viswanathan; Renée F de Bruijn; Aad van der Lugt; Albert Hofman; Peter J Koudstaal; M Arfan Ikram; Meike W Vernooij
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

6.  The prevalence and risk factors of cerebral microbleeds in patients with Parkinson's disease.

Authors:  Kazuo Yamashiro; Ryota Tanaka; Yasunobu Hoshino; Taku Hatano; Kenya Nishioka; Nobutaka Hattori
Journal:  Parkinsonism Relat Disord       Date:  2015-06-26       Impact factor: 4.891

Review 7.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

Authors:  Dennis W Dickson; Heiko Braak; John E Duda; Charles Duyckaerts; Thomas Gasser; Glenda M Halliday; John Hardy; James B Leverenz; Kelly Del Tredici; Zbigniew K Wszolek; Irene Litvan
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

Review 8.  Dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

9.  Relationship between cerebral microbleeds location and cognitive impairment in patients with ischemic cerebrovascular disease.

Authors:  Jianjun Yang; Yongtao Lyu; Yue Ma; Yan Chen
Journal:  Neuroreport       Date:  2018-09-26       Impact factor: 1.837

Review 10.  Parkinson's disease subtypes: lost in translation?

Authors:  Connie Marras; Anthony Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-05       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.